NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

Clinical trial NCT06763302 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06763302
Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

B Cell Precursor Acute Lymphoblastic Leukemia Pediatric Minimal Residual Disease Next Generation Sequencing (NGS)

Start date: 2025-01-01
Primary completion: 2027-12-31
Enrollment: 1220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.